By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catabasis Pharmaceuticals, Inc. 

161 First Street
Suite 1A
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-349-1971 Fax: 617-273-2637


SEARCH JOBS


Industry
Pharmaceutical






Company News
Catabasis Pharma To Present Pre-Clinical Data Supporting CAT-2054 As A Potential Treatment For Nonalcoholic Steatohepatitis (NASH) At Digestive Disease Week 2016 5/16/2016 10:30:12 AM
Catabasis Pharma To Present CAT-2054, A Potential Treatment For Nonalcoholic Steatohepatitis (NASH) And Hypercholesterolemia, At The National Lipid Association 2016 Scientific Sessions 5/16/2016 10:28:53 AM
Catabasis Pharma Reports First Quarter 2016 Financial Results And Recent Corporate Highlights 5/13/2016 8:49:06 AM
Catabasis Pharma To Report First Quarter 2016 Financial Results And Recent Corporate Developments On Thursday, May 12 4/28/2016 11:20:13 AM
Catabasis Pharma Initiates Part B Of The MoveDMD Trial Of CAT-1004 For The Treatment Of Duchenne Muscular Dystrophy 4/12/2016 10:15:55 AM
Catabasis Pharma CFO Steps Down for Biopharma Startup 4/4/2016 6:08:58 AM
Catabasis Pharma To Present CAT-1004 Data From Part A Of The MoveDMD Trial At The 2016 Muscular Dystrophy Association Clinical Conference 3/18/2016 8:54:36 AM
Catabasis Pharma To Present At Cowen and Company’s 36th Annual Health Care Conference 3/3/2016 11:13:42 AM
Catabasis Pharma Reports Fourth Quarter And Full Year 2015 Financial Results And Recent Corporate Developments 3/3/2016 11:11:06 AM
Catabasis Pharma To Report Fourth Quarter And Full Year 2015 Financial Results And Recent Corporate Developments On Wednesday, March 2 2/17/2016 10:01:45 AM
123456789
//-->